Efficacy and safety of endoscopic submucosal dissection for gastric cancer in patients with liver cirrhosis

Endoscopy. 2008 May;40(5):443-5. doi: 10.1055/s-2007-995650.

Abstract

Endoscopic submucosal dissection (ESD) has become a widely accepted method for treating gastrointestinal cancer. The aim of this study was to evaluate the efficacy and safety of ESD for gastric cancer in patients with liver cirrhosis. A total of 18 gastric cancers were treated by ESD in 15 patients with cirrhosis. The rate of en bloc resection was 88.9% (16/18). En bloc resection with tumor-free lateral/basal margins (R0 resection) was 77.8% (14/18). Three patients had postoperative bleeding and underwent emergency gastroscopy for hemostasis. No recurrence was observed during the median follow-up of 21.4 months, excluding three patients in whom additional endoscopic resection or surgery was carried out. ESD can be safely performed for gastric cancer in patients with cirrhosis, resulting in a high en bloc resection rate.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • Dissection*
  • Endoscopy, Gastrointestinal*
  • Female
  • Gastric Mucosa / surgery*
  • Humans
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / surgery
  • Male
  • Middle Aged
  • Stomach Neoplasms / complications
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery*
  • Treatment Outcome